Financials
- Market Capitalization 1.95 B
- Employee 59
- Founded 2019
- CEO N/A
- Website www.sionnatx.com
- Headquarter Delaware, United States
- FIGI BBG016X2DC85
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.55
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2013 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -0.22% | +16.97% | +118.43% | 1.98 B USD | ||
| 2016 | NBTX Nanobiotix S.A. - ADSs | 40.02 USD | -3.89% | +4.06% | +13.05% | +659.39% | 1.94 B USD | ||
| 2032 | TYRA Tyra Biosciences, Inc. - Common Stock | 31.86 USD | -3.10% | +0.03% | +11.59% | +122.18% | 1.89 B USD | ||
| 2034 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.31 USD | -3.62% | -13.54% | +9.77% | -5.41% | 1.83 B USD |